Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline vs Comparator in Pediatric cSSSI
NCT00911573Phase 3Withdrawn
- Sponsor
- Pfizer
- Start
- Aug 2011
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of tigecycline in Skin and Skin Structure Infection (SSSI), sponsored by Pfizer. Planned start Aug 2011; status: withdrawn.
02
Drugs
tigecycline
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00911573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911573.